v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Jun. 30, 2025
Mar. 31, 2025
Cash flows from operating activities:        
Net loss $ (15,157) $ (13,503) $ (15,390) $ (15,925)
Adjustments to reconcile net loss to net cash used in operating activities:        
Share-based compensation expense 2,780     2,745
Depreciation and amortization 104     118
Amortization of right-of-use asset - operating 99     94
Change in operating assets and liabilities:        
Prepaid and other assets 281     731
Accounts payable, accrued and other liabilities (905)     (1,678)
Lease liabilities (140)     (130)
Other long-term liabilities       40
Net cash used in operating activities (12,938)     (14,005)
Cash flows from investing activities:        
Purchases of property and equipment (5)     (18)
Net cash used in investing activities (5)     (18)
Cash flows from financing activities:        
Payment of issuance costs associated with the Concurrent Financing       (37)
Payment of reverse recapitalization transaction costs       (40)
Net cash provided by (used in) financing activities 145,999     (77)
Net increase (decrease) in cash and cash equivalents 133,056     (14,100)
Cash and cash equivalents, beginning of period 59,050   $ 96,661 110,761
Cash and cash equivalents, end of period 192,106 $ 59,050   $ 96,661
Supplemental disclosure of noncash financing activities:        
2026 Private Placement proceeds in other current assets (4,000)      
2026 Private Placement issuance costs included in accounts payable 9,372      
2026 Private Placement issuance costs included in accrued liabilities 81      
2026 Private Placement        
Cash flows from financing activities:        
Proceeds from the issuance of Class A Common Stock and pre-funded warrants in connection with 2026 Private Placement $ 145,999